Colorectal cancer

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 1, 1999, Pages 37-39

  Northover, John ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER SCREENING; CANCER SURGERY; COLORECTAL CANCER; HUMAN; LAPAROSCOPIC SURGERY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033044135     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199901000-00008     Document Type: Short Survey

References (22)

1. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328:614-616.
2. Graden J, Thliveris A, Samowitz W. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66:589-600.
3. Parsons R, Li G-M, Rao M. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75:1227-1236.
4. Fishel R, Lescoe M, Rao M. The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75:1027-1038.
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley M, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
6. Hardcastle J, Chamberlain J, Robinson M, Moss S, et al. Randomised trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
7. Kronborg O, Fenger C, Olsen J, Jorgensen O, Sandergaard O. Randomised trial of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348:1467-1471.
8. Atkin W, Cuzick J, Northover J, Whynes D. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341:736-740.
9. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival [see comments]. BMJ 1991; 302:1501-1505.
10. Guidance on Commissioning Cancer Services: Improving Outcomes in Colorectal Cancer. The Research Evidence. Leeds: NHS Executive; 1997.
11. Heald R, Ryall R. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; i:1479-1482.
12. Arbman G, Nilsson E, Halbrook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83:375-379.
13. Scholefieid J, Northover J. Surgical management of rectal cancer. Br J Surg 1995; 82:745-748.
14. Jager R, Wexner S (editors). Laparoscopic Colorectal Surgery. New York: Churchill Livingstone; 1996.
15. Hartley J, Monson J. The lower gastrointestinal tract: colorectal cancer. In: Laparoscopic Surgery. Hobsley M, Treasure T, Northover J (editors). London: Arnold; 1998.
16. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989; 7:1447-1456.
17. The Efficacy and the Group C Status of Levamisole and 5-Fluorouracil for Patients with Dukes' C Colon Cancer. National Cancer Institute Press Release, 1989.
18. Moertel C, Fleming T, McDonald J. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995; 122:321-326.
19. Gray R, Northover J. Adjuvant treatment for colorectal cancer. Concerns about chemotherapy are legitimate [letter; comment]. BMJ 1996; 312:1417-1418.
20. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345:939-944.
21. Graf W, Dahlberg M, Ohlberg M, Holmberg L, Pahlman L, Glimelius B. Short term preoperative radiotherapy results in down staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997; 43:133-137.
22. Codemark B, Johannson H, Rutquarist L, Wilking N. Randomised study on preoperative radiotherapy in rectal cancer. Ann Surg Oncol 1996; 3:423-430.